参考文献 References
[1] Kaplan G G. The global burden of inflammatory bowel disease in the 21st century [J]. Nature Reviews Gastroenterology & Hepatology, 2020, 14(12): 134–142.
[2] Shang S, et al. Limitations of anti-TNF biologics for ulcerative colitis and engineered probiotic alternatives [J]. Advanced Science, 2025,13: 114–132.
[3] Xu L. Surface layer proteins of Lactobacillus: adhesion, immune regulation and anti-inflammatory functions [J]. Journal of Applied Microbiology, 2021,12: 14–22.
[4] Gro-EL from Bifidobacterium animalis H15 alleviates DSS-induced colitis via mucosal barrier restoration [J]. Journal of Functional Foods, 2021,11: 104–112.
[5] Wang Y. Surface proteins of Lactobacillus acidophilus NCFM ameliorate TNF-α-triggered intestinal epithelial barrier dysfunction [J]. Food & Function, 2019,14: 121–125.
[6] Sengupta S. Cell surface components of lactic acid bacteria modulate gut microbiota homeostasis and pathogen inhibition [J]. Microbiological Research,,2018,12: 11–15.
[7] Anti-inflammation and adhesion enhancement properties of the multifunctional LPxTG-motif surface protein derived from the Lactobacillus reuteri DSM 8533[J]. Molecular Immunology, Pergamon, 2022, 146: 38–45.
[8] Li T, Zhu K, Wang L, et al. Stabilization by Chaperone GroEL in Biogenic Selenium Nanoparticles Produced from Bifidobacterium animalis H15 for the Treatment of DSS-Induced Colitis[J]. ACS Applied Materials & Interfaces, American Chemical Society, 2024, 16(11): 13439–13452.
[9] Ruiz L, Delgado S, Ruas-Madiedo P, et al. Bifidobacteria and Their Molecular Communication with the Immune System[J]. Frontiers in Microbiology, Frontiers, 2017, 8.
[10] Wang H, Zhang L, Li Q, et al. Surface-layer protein produced by Lactobacillus crispatus JCM 2009 ameliorates lipopolysaccharide-induced inflammation through autophagy cross-talk with the NF-κB signaling pathway[J]. International Journal of Biological Macromolecules, 2021, 166: 633–640.
[11] Wang H, Zhang Q, Niu Y, et al. Surface-layer protein from Lactobacillus acidophilus NCFM attenuates tumor necrosis factor-α-induced intestinal barrier dysfunction and inflammation[J]. International Journal of Biological Macromolecules, 2019, 136: 27–34.
[12] Sengupta R, Altermann E, Anderson R C, et al. The Role of Cell Surface Architecture of Lactobacilli in Host-Microbe Interactions in the Gastrointestinal Tract[J]. Mediators of Inflammation, Hindawi, 2013, 2013: e237921.
[13] Dömling A, Li X. TNF-α: The shape of small molecules to come[J]. Drug Discovery Today, 2022, 27(1): 3–7.
[14] Al-Sadi R, Guo S, Ye D, et al. TNF-α Modulation of Intestinal Epithelial Tight Junction Barrier Is Regulated by ERK1/2 Activation of Elk-1[J]. The American Journal of Pathology, 2013, 183(6): 1871–1884.
[15] Al-Sadi R, Guo S, Ye D, et al. TNF-α Modulation of Intestinal Tight Junction Permeability Is Mediated by NIK/IKK-α Axis Activation of the Canonical NF-κB Pathway[J]. The American Journal of Pathology, 2016, 186(5): 1151–1165.
[16] Zelová H, Hošek J. TNF-α signalling and inflammation: interactions between old acquaintances[J]. Inflammation Research, 2013, 62(7): 641–651.
[17] Yuan Y, Ding D, Zhang N, et al. TNF-α induces autophagy through ERK1/2 pathway to regulate apoptosis in neonatal necrotizing enterocolitis model cells IEC-6[J]. Cell Cycle, Taylor & Francis, 2018, 17(11): 1390–1402.
[18] Ben-Horin S, Kopylov U, Chowers Y. Optimizing anti-TNF treatments in inflammatory bowel disease[J]. Autoimmunity Reviews, 2014, 13(1): 24–30.
[19] Xiao P, Hu Z, Lang J, et al. Mannose metabolism normalizes gut homeostasis by blocking the TNF-α-mediated proinflammatory circuit[J]. Cellular & Molecular Immunology, Nature Publishing Group, 2023, 20(2): 119–130.
[20] Songkiatisak P, Rahman S M T, Aqdas M, et al. NF-κB, a culprit of both inflamm-ageing and declining immunity[J]. Immunity & Ageing, 2022, 19(1): 20.
[21] Hansen S K, Baeuerle P A, Blasi F. Purification, Reconstitution, and IκB Association of the c-Rel-p65 (RelA) Complex, a Strong Activator of Transcription[J]. Molecular and Cellular Biology, Taylor & Francis, 1994, 14(4): 2593–2603.
[22] Ma Z, Du B, Li J, et al. An Insight into Anti-Inflammatory Activities and Inflammation Related Diseases of Anthocyanins: A Review of Both In Vivo and In Vitro Investigations[J]. International Journal of Molecular Sciences, Multidisciplinary Digital Publishing Institute, 2021, 22(20): 11076.
[23] Zhang C, Deng Y, Zhang Y, et al. CXCR3 Inhibition Blocks the NF-κB Signaling Pathway by Elevating Autophagy to Ameliorate Lipopolysaccharide-Induced Intestinal Dysfunction in Mice[J]. Cells, Multidisciplinary Digital Publishing Institute, 2023, 12(1): 182.
[24] Franke T F. PI3K/Akt: getting it right matters[J]. Oncogene, Nature Publishing Group, 2008, 27(50): 6473–6488.
[25] Nascimbeni A C, Codogno P, Morel E. Phosphatidylinositol-3-phosphate in the regulation of autophagy membrane dynamics[J]. The FEBS Journal, 2017, 284(9): 1267–1278.
[26] Zhang J, Cen L, Zhang X, et al. MPST deficiency promotes intestinal epithelial cell apoptosis and 16 aggravates inflammatory bowel disease via AKT[J]. Redox Biology, 2022, 56: 102469.
[27] Moparthi L, Koch S. Wnt signaling in intestinal inflammation[J]. Differentiation, 2019, 108: 24–32.
[28] Li J, Li Q, Wu Q, et al. Exopolysaccharides of Lactobacillus rhamnosus GG ameliorate Salmonella typhimurium-induced intestinal inflammation via the TLR4/NF-κB/MAPK pathway[J]. Journal of Animal Science and Biotechnology, 2023, 14(1): 23.
[29] Haftcheshmeh S M, Abedi M, Mashayekhi K, et al. Berberine as a natural modulator of inflammatory signaling pathways in the immune system: Focus on NF-κB, JAK/STAT, and MAPK signaling pathways[J]. Phytotherapy Research, 2022, 36(3): 1216–1230.